Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A **mineral electrolyte combination** containing potassium chloride, sodium chloride, and calcium chloride. This type of product is used to replace or supplement essential extracellular and intracellular ions and is typically intended for correction or prevention of **electrolyte depletion**, support of **fluid and acid-base balance**, or use in compounded/reconstitution settings depending on formulation. Pharmacologically, the activity is based on direct provision of physiologic ions rather than receptor-selective pharmacology: **sodium** is the principal extracellular cation involved in osmotic balance and nerve and muscle function, **potassium** is the major intracellular cation required for membrane potential and cardiac and neuromuscular excitability, and **calcium** supports neuromuscular transmission, muscle contraction, and multiple signaling processes. The exact clinical use, dose form, route, and regulatory status are formulation-specific, and the queried name denotes the ingredient combination rather than a uniquely identifiable branded product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium chloride + sodium chloride + calcium chloride.